南美洲病毒样颗粒市场预测至 2028 年 - 按产品类型(肝炎、癌症/HPV 和戈谢病)、来源(酵母、昆虫细胞、植物等)和应用(疫苗)划分的 COVID-19 影响和区域分析和治疗)

TIPRE00026835 | Pages: 104 | Pharmaceuticals | Jan 2022 | Type: Regional | Status: Published

市场介绍

南美洲分析的主要国家包括阿根廷、巴西和南美洲其他地区。该地区病毒样颗粒市场的增长归因于人口老龄化、诊断市场的蓬勃发展以及制药行业主要参与者不断采取的举措。由于最近的技术发展对巴西经济产生了直接影响,并在很大程度上取得了进步,因此市场可能会在预测期内得到推动。南美洲每年约有 10 万例急性乙型肝炎病毒 (HBV) 感染病例。低危人群中乙型肝炎(HBV)感染的总体患病率为6.7%至41%,而乙型肝炎表面抗原(HBsAg)感染率为0.4%至13%。在高流行的原住民或农村人口中,围产期传播可能在乙型肝炎 (HBV) 的传播中发挥重要作用。

随着南美洲成为 COVID-19 的新震中人们越来越担心依赖海外设计和制造的疫苗,特别是因为富裕国家历来更容易获得免疫接种。南美洲各国政府迅速采取先发制人的行动,保护其公民并控制 COVID-19 在该地区的传播及其经济后果。据报道,某些高收入国家政府已尝试购买疫苗制造公司或其部分供应。研究人员称,他们用冠状病毒用来进入人体细胞的蛋白质片段包裹病毒样颗粒,希望欺骗免疫系统产生抗体,在感染过程中阻止冠状病毒。由于这些颗粒无法在人体内复制,而且这种类病毒颗粒被认为比由弱化病毒制成的疫苗更安全,因此该技术已被用于开发商业上可获得的乙型肝炎和人乳头瘤病毒疫苗。此外,阿根廷和墨西哥于 2020 年 8 月与 mAbxience、英国制药公司阿斯利康和牛津大学签署了一项协议。目标是生产 150 至 2.5 亿剂 COVID-19 疫苗,并将在整个南美洲分发。预计将帮助该地区抗击 COVID-19。

 

市场概况和动态

南美类病毒颗粒市场预计将从2021年的1.9978亿美元增长到2028年的3.2457亿美元;预计 2021 年至 2028 年复合年增长率为 7.2%。疫苗是制药行业的重要组成部分之一。它们在人类和动物针对常见感染的免疫中具有广泛的应用。在药品和生物制药市场运营的公司不断关注产品创新和开发,以维持市场竞争。例如,市场参与者一直在大力投资 COVID-19 疫苗的开发以及与 VLP 相关的研究。生命科学公司的积极发展,加上政府的支持,正在促进 VLP 市场的增长。

关键细分市场

从产品类型来看,肝炎细分市场在2021年南美病毒样颗粒市场中占据最大份额。从来源来看,酵母细分市场在2021年南美病毒样颗粒市场中占据最大份额。从应用来看,疫苗细分市场在2021年病毒样颗粒市场中占有较大份额。

主要来源和上市公司

准备时参考的一些主要一手和二手来源这份关于南美类病毒颗粒市场的报告包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司是默克公司(Merck & Company)。有限公司;葛兰素史克公司;辉瑞公司;赛诺菲;印度血清研究所列兵。有限公司;巴拉特生物技术公司;和 LG 化学等

购买原因报告

  • 了解南美洲病毒样颗粒市场格局并确定最有可能保证强劲回报的细分市场
  • 了解南美洲病毒样颗粒市场不断变化的竞争格局,保持领先地位
  • 高效通过确定最有可能销售前景的细分市场,规划南美类病毒颗粒市场的并购和合作交易
  • 帮助通过敏锐和全面的分析做出明智的业务决策南美病毒样颗粒市场各个细分市场的市场表现
  • 获取南美地区2021-2028年各个细分市场的市场收入预测

南美类病毒颗粒市场细分

 

南美洲病毒样颗粒市场 - 按产品类型

  • 肝炎
  • 癌症/HPV
  • 戈谢病

南美洲病毒样颗粒市场 - 按来源

  • 酵母
  • 昆虫细胞
  • 植物
  • 其他

南美洲病毒样颗粒市场 - 作者:应用

  • 疫苗
  • 治疗

南美洲病毒样颗粒市场 - 按国家/地区

  • 巴西
  • 阿根廷
  • SAM 其余地区    

南美类病毒颗粒市场 - 提及的公司

  • 默克公司                   ;                  &n公共服务提供商;      
  • 葛兰素史克公司
  • 辉瑞公司;                  &n公共服务提供商;                  &n公共服务提供商;              
  • 赛诺菲;                  &n公共服务提供商;                  &n公共服务提供商;                   
  • 印度血清研究所列兵。                       
  • 巴拉特生物科技            ;                           ;         
LG化学       ;                  &n公共服务提供商;              

1.          Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South America Virus-like Particles Market – By Product Type

1.3.2        South America Virus-like Particles Market – By Source

1.3.3        South America Virus-like Particles Market – By Application

1.3.4        South America Virus-like Particles Market – By Country

2.           South America Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South America Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           South America Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Up-raising Prevalence of Infectious Viral Diseases

5.1.2        Surging Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Availableness of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Scaling Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Consistent Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           South America Virus-like Particles Market Analysis

6.1         South America Virus-like Particles Market Revenue Forecast and Analysis

7.           South America Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         South America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           South America Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         South America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           South America Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         South America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        South America Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     South America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.3       Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       Brazil Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.1.5       Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.3       Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       Argentina: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.2.5       Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Rest of South America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       Rest of South America: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.3.5       Rest of South America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on South America Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        South America Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Serum Institute of India Pvt. Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      BHARAT BIOTECH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      LG Chem

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             South America Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 6.             Argentina: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             Rest of South America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 9.             Rest of South America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          Rest of South America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments Done by Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms: Virus-like Particles Market

 


LIST OF FIGURES

Figure 1.           South America Virus-like particles Market Segmentation

Figure 2.           South America Virus-like particles Market Segmentation, By Country

Figure 3.           South America Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in South America Virus-like particles Market

Figure 5.           Brazil to Show Significant Growth during Forecast Period

Figure 6.           South America Virus-like Particles Market, Industry Landscape

Figure 7.           South America PEST Analysis

Figure 8.           South America Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           South America Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        South America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        South America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        South America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        South America Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 23.        South America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Impact Of COVID-19 Pandemic in South America Country Markets

  1. Merck & Co., Inc.                                                       
  2. GlaxoSmithKline plc.                                                
  3. Pfizer Inc.                                                                    
  4. Sanofi                                                                         
  5. Serum Institute of India Pvt. Ltd.                           
  6. BHARAT BIOTECH                                                      
  7. LG Chem                                                                     
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South America virus-like particles market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South America virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South America market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000